期刊
MEDICAL MOLECULAR MORPHOLOGY
卷 42, 期 4, 页码 195-200出版社
SPRINGER JAPAN KK
DOI: 10.1007/s00795-009-0471-x
关键词
Insulin-producing cell (IPC); Pancreatic stem cell; Diabetes mellitus; CD133; ES cells; iPS cells
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan
One of the most common diseases of the pancreas is diabetes mellitus. The current treatment of exogenous insulin supply is not fully capable of achieving tight control of glucose regulation, leading to long-term complications. Hence, recent success in islet transplantation-based therapies for diabetes mellitus and the extreme shortage of pancreatic islets have motivated recent efforts to develop renewable sources of islet-replacement tissue. Of clinical interest, I review the recent progress on stem cell-based strategies for diabetes in view of regenerative medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据